Immix Biopharma, Inc.
IMMX
$2.00
-$0.12-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.90% | -9.96% | -10.20% | -17.87% | -18.23% |
| Total Receivables | -- | -- | -0.05% | -0.25% | -2.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.28% | 35.45% | -51.65% | -17.06% | -9.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -18.23% | 421.36% | -11.51% | -65.50% | -39.61% |
| Total Current Assets | -26.54% | -16.93% | -11.24% | -16.74% | -16.97% |
|
|
|||||
| Total Current Assets | -26.54% | -16.93% | -11.24% | -16.74% | -16.97% |
| Net Property, Plant & Equipment | 2.79% | 13.29% | 15.39% | 59.33% | 5.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 542.16% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -21.40% | -13.32% | -8.73% | -12.81% | -16.05% |
|
|
|||||
| Total Accounts Payable | 15.19% | 6.56% | 63.85% | 40.14% | -33.20% |
| Total Accrued Expenses | -4.93% | 8.17% | 0.63% | 113.23% | -28.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.98% | 3.99% | 3.99% | 29.55% | 41.11% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.55% | 7.14% | 32.33% | 68.24% | -31.02% |
|
|
|||||
| Total Current Liabilities | 7.55% | 7.14% | 32.33% | 68.24% | -31.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.90% | -1.83% | -1.63% | -1.58% | -1.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.64% | 6.21% | 27.74% | 53.51% | -26.37% |
|
|
|||||
| Common Stock & APIC | 1.83% | 0.98% | 0.80% | 0.84% | 0.39% |
| Retained Earnings | -8.32% | -6.05% | -6.85% | -11.34% | -7.49% |
| Treasury Stock & Other | 58.70% | 16.34% | -209.66% | 441.76% | 265.05% |
| Total Common Equity | -51.50% | -27.60% | -24.50% | -26.54% | -14.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -51.50% | -27.60% | -24.50% | -26.54% | -14.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -51.50% | -27.60% | -24.50% | -26.54% | -13.54% |
|
|
|||||